Atrial Natriuretic Peptide (ANP) (1-28), rat is a major circulating form of ANP in rats, potently inhibits Angiotensin II (Ang II)-stimulated endothelin-1 secretion in a concentration-dependent manner.
CAT No: R1223
CAS No:88898-17-3
Synonyms/Alias:Cardiodilatin;Cardiodilatin-126;88898-17-3;CDD-ANP-99-126;Atrial Natriuretic Peptide rat;Cardiodilation-atrial natriuretic peptide;92047-08-0;Atrial Natriuretic Factor (1-28) (mouse, rabbit, rat) H-Ser-Leu-Arg-Arg-Ser-Ser-Cys-Phe-Gly-Gly-Arg-Ile-Asp-Arg-Ile-Gly-Ala-Gln-Ser-Gly-Leu-Gly-Cys-Asn-Ser-Phe-Arg-Tyr-OH (Disulfide bond);AKOS024456849;Atrial natriuretic factor(1-28)(rat);FA73200;Atrial Natriuretic Peptide (1-28), rat;DA-61305;PD076374;Atrial Natriuretic Peptide rat, >=97% (HPLC);Atrial Natriuretic Factor (1-28) (mouse, rabbit, rat) trifluoroacetate salt;
1. Cationic cell-penetrating peptides are potent furin inhibitors
2. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.